Food or edible material: processes – compositions – and products – Products per se – or processes of preparing or treating... – Fat or oil is basic ingredient other than butter in emulsion...
Reexamination Certificate
2008-01-29
2008-01-29
Berch, Mark L. (Department: 1624)
Food or edible material: processes, compositions, and products
Products per se, or processes of preparing or treating...
Fat or oil is basic ingredient other than butter in emulsion...
C426S801000
Reexamination Certificate
active
07323206
ABSTRACT:
Materials and methods for preparing and using All-in-One (“AIO”) formulations suitable for administration to infants and neonates for total parenteral nutrition are provided.
REFERENCES:
patent: 4857555 (1989-08-01), Smith et al.
patent: 5039704 (1991-08-01), Smith et al.
patent: 5053387 (1991-10-01), Alexander
patent: 5196198 (1993-03-01), Shaw et al.
patent: 5206220 (1993-04-01), Hilton
patent: 5231085 (1993-07-01), Alexander et al.
patent: 5248697 (1993-09-01), Wilmore
patent: 5276018 (1994-01-01), Wilmore
patent: 5288703 (1994-02-01), Wilmore
patent: 5292722 (1994-03-01), Wilmore
patent: 5397803 (1995-03-01), Smith et al.
patent: 5461037 (1995-10-01), Cotter
patent: 5574065 (1996-11-01), Trimbo
patent: 5576351 (1996-11-01), Yoshimura et al.
patent: 5607975 (1997-03-01), Smith et al.
patent: 5684045 (1997-11-01), Smith et al.
patent: 5700837 (1997-12-01), Trimbo
patent: 5731346 (1998-03-01), Egberg et al.
patent: 5733884 (1998-03-01), Barbul et al.
patent: 5747533 (1998-05-01), Egberg et al.
patent: 5760020 (1998-06-01), Cotter
patent: 5760157 (1998-06-01), Cerf et al.
patent: 5763485 (1998-06-01), Smith et al.
patent: 5766621 (1998-06-01), Trimbo et al.
patent: 5843465 (1998-12-01), Lundquist
patent: 5874470 (1999-02-01), Nehne et al.
patent: 5886037 (1999-03-01), Klor et al.
patent: 5977175 (1999-11-01), Lin
patent: 6008248 (1999-12-01), Pscherer et al.
patent: 6036992 (2000-03-01), Borror et al.
patent: 6077828 (2000-06-01), Abbruzzese et al.
patent: 6096338 (2000-08-01), Lacy et al.
patent: 6200950 (2001-03-01), Mark et al.
patent: 6267985 (2001-07-01), Chen et al.
patent: 6284268 (2001-09-01), Mishra et al.
patent: 6306908 (2001-10-01), Carlson et al.
patent: 6313167 (2001-11-01), Nakajima et al.
patent: 6355609 (2002-03-01), Mallangi et al.
patent: 6552081 (2003-04-01), Freedman et al.
patent: 6720001 (2004-04-01), Chen et al.
patent: 6761903 (2004-07-01), Chen et al.
patent: WO9719683 (1997-06-01), None
Driscoll et al., “Physicochemical stability assessments of lipid emulsions of varying oil composition,” Clinical Nutrition (2001) vol. 20(2); pp. 151-157.
Sato et al. “Hyrolysis of Mixed Lipid Emulsions Containing Medium-Chain and Long-Chain Triacylglycerol With Lipoprotein Lipase in Plasma-like Medium,” Journal of Parenteral and Enteral Nutrition, 1994, vol. 18, No. 2, pp. 112-118.
Heird, et al., Annual Review of Nutrition, 1996, 16:471-99.
Kraus, http://www.uic.edu/classes/pmpr/pmpr652/Final/krauss/pedsnutrition.html; Spring 1998.
Glahn, et al., J. Nutrition, 1998, pp. 257-264.
Heine, et al., J. Nutrition, 1991, pp. 277-283.
Abbott et al., “Metabolic and Respiratory Effects of Continuous and Discontinuous Lipid Infusions,” Arch. Surg., Dec. 1984, vol. 119, pp. 1367-1371.
Avila-Figueroa et al., “Intravenous Lipid Emulsions Are The Major Determinant of Coagulase-NegativeStaphylococcal bacteremiaIn Very Low Birth Weight Newborns,” Pediatr. Infect. Dis. J., 1998, vol. 17, No. 1, pp. 10-17.
Bach et al., “Medium-Chain Triglycerides: An Update,” The American Journal of Clinical Nutrition, 36, Nov. 1982, pp. 950-962.
Bennett et al., “Postoperative Infections Traced to Contamination Of An Intravenous Anesthetic Propofol,” Jul. 20, 1995, vol. 333, No. 3, pp. 147-154.
D'Angio et al., “Effect of the Mode of Lipid Administration of Parenteral Nutrition-Related Infections,” The Annals of Pharmacotherapy, Jan. 1992, vol. 26, pp. 14-17.
Deckelbaum et al., “Medium-Chain Versus Long-Chain Triacylglycerol Emulsion Hydrolysis by Lipoprotein Lipase and Hepatic Lipase: Implications for the Mechanisms of Lipase Action,” Biochemistry, 1990, 29, pp. 1136-1142.
Didier et al., “Total Nutrient Admixtures Appear Safer Than Lipid Emulsion Alone As Regards Microbial Contamination: Growth Properties of Microbial Pathogens at Room Temperature,” Journal of Parenteral and Enteral Nutrition, Sep./Oct. 1998, vol. 22, No. 5, pp. 291-296.
Driscoll et al., “Physicochemical Assessments of Parenteral Lipid Emulsions: Light Obscuration Versus Laser Diffraction,” International Journal of Pharmaceutics, 219, 2001, pp. 21-37.
Driscoll et al., “Physicochemical Stability Assessments of Lipid Emulsions of Varying Oil Composition,” Clincial Nutrition, 2001, 20(2), pp. 151-157.
Driscoll et al., “Physicochemical Stability of Intravenous Lipid Emulsions As All-In-One Admixtures Intended for the Very Young,” Clinical Nutrition, 2003. 22(5), pp. 489-495.
Driscoll et al., “Physicochemical Stability of Total Nutrient Admixtures,” Am. J. Health-Syst. Pharm., vol. 52, Mar. 15, 1995, pp. 623-624.
Driscoll et al., “Physicochemical Stability of Two Types of Intravenous Lipid Emulsion As Total Nutrient Admixtures,” Journal of Parenteral and Enteral Nutrition, Jan.-Feb. 2000, vol. 24, No. 1, pp. 15-22.
Driscoll et al., “The Influence of Medium-Chain Triglycerides on the Stability of All-In-One Formulations,” International Journal of Pharmaceutics, 240, 2002, pp. 1-10.
Driscoll, David, “Clinical Issues Regarding the Use of Total Nutrient Admixtures,” DICP, The Annals of Pharmacotherapy, vol. 24, Mar. 1990, pp. 296-303.
Driscoll, David, “Physicochemical Assessment of Total Nutrient Admixure Stability and Safety: Quantifying the Risk,” Nutrition, vol. 13, No. 2, 1997, pp. 166-167.
Driscoll, David, “The Significance of Particle/Globule-Sizing Measurements In the Safe Use of Intravenous Lipid Emulsions,” Journal of Dispersion Science and Technology, vol. 23, No. 5, 2002, pp. 679-687.
Driscoll, David, “Total Nutrient Admixtures: Theory and Practice,” Nutrition In Clinical Practice, vol. 10, No. 3, Jun. 1995, pp. 114-119.
El-Ebiary et al., “Lipid Deposition During the Long-Term Infusion of Propofol,” Critical Care Medicine, vol. 23, No. 11, Nov. 1995, pp. 1928-1930.
Freeman et al., “Association of Intravenous Lipid Emulsion and Coagulase-NegativeStaphylococcal bacteremiaIn Neonatal Intensive Care Units,” The New England Journal of Medicine, Aug. 2, 1990, vol. 323, No. 5, pp. 301-308.
Hamberger et al., “More Efficient Clearance of Intravenous (I.V.) Lipid Emulsions Containing Medium Chain Triglyceride (MCT) And Fish Oil Triglycerides (Ω-3 TG) As Compared to Traditional Long Chain Triglyceride (LCT) Lipid Emulsions In In Vitro Models and Humans” Abstracts No. 2988, Apr. 1998.
Hamilton et al., “Incorporation of Medium Chain Triacylglycerols Into Phospholipid Bilayers: Effect of Long Chain Triacylglycerols, Cholesterol, and Cholesteryl Esters,” Journal of Lipid Research, vol. 37, 1996, pp. 773-782.
Hulman, Geoffrey, “The Pathogenesis of Fat Embolism,” Journal of Pathology, 1995, vol. 176, pp. 3-9.
Jarvis et al., Polymicrobial Bacteremia Associated with Lipid Emulsion In A Neonatal Intensive Care Unit, May 1983, vol. 2, No. 3, pp. 203-208.
Khaodhiar et al., “Perioperative Hyperglycemia, Infection or Risk?,” vol. 2(1), Jan. 1999, pp. 79-82.
Kim et al., “Bacterial and Fungal Growth In Intravenous Fat Emulsions,” Am. J. Hosp. Pharm., Dec. 1983, vol. 40, pp. 2159-2161.
Klein et al., “Metabolic Effects of Long-Chain and Medium-Chain Triglyceride Emulsions In Humans,” Journal of Parenteral and Enteral Nutrition, Sep.-Oct. 1994, vol. 18, No. 5, pp. 396-397.
Matlow et al., “A Randomized Trial of 72-Versus 24-Hour Intravenous Tubing Set Changes in Newborns Receiving Lipid Therapy,” Infection Control and Hospital Epidemiology, Jul. 1999, vol. 20, No. 7, pp. 487-493.
McKee et al., “Gram-Negative Bacillary Sepsis Associated With Use of Lipid Emulsion in Parenteral Nutrition,” Am. J. Dis. Child, Jun. 1979, vol. 133, pp. 649-650.
Melly et al., “Microbial Growth in Lipid Emulsions Used in Parenteral Nutrition,” Arch. Surg, Dec. 1975, vol. 110, pp. 1479-1481.
Moore, Frederick, “Caution: Use Fat Emulsions Judiciously
Bistrian Bruce
Driscoll David
B. Braun Medical Inc.
Berch Mark L.
Christie Parker & Hale LLP
Jaisle Cecilia M
LandOfFree
Reagents and methods for all-in-one total parenteral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents and methods for all-in-one total parenteral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents and methods for all-in-one total parenteral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2772752